Unilever Vows No GSK-Sized Ventures For Foreseeable Future, Commits To Existing Brands In 2022

Opening the company’s fiscal 2021 full-year earnings call, Unilever leadership assured investors it will not make any GSK-sized offers in the foreseeable future as it commits to organic growth and reshaping its portfolio more surgically through bolt-on deals and selective disposals.

Stock market (photofriday/Shutterstock.com)

Hearing the call of its investors, Unilever PLC has “drawn a line under the GSK Consumer Health proposal” and does not intend to pursue other major acquisitions in the foreseeable future, CEO & Executive Director Alan Jope told analysts during a 10 February year-end earnings presentation.

“We listened carefully to shareholders and we’ve heard the message that there’s currently no support for a move the size...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

Church & Dwight’s Options For Vitamin Brands: Divest, Find Partner, Shrink Business

 

Divesting C&D’s vitamin business, says CEO Richard Dierker, is “probably the cleanest option” as brands remain a drag on earnings after second quarter.

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By 

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.

US Consumer Health Q2 Earnings Preview: Baggage Comes With Costs, Expectations

 

In addition to impact from tariffs and executive suite changes, recent baggage for firms in the space include Perrigo divesting its branded Dermacosmetics business and Church & Dwight acquiring Touchland hand sanitizer brand.

Expanded Distribution In US Helps Drive Up BioGaia Sales

 
• By 

Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.

More from Wellness

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.

US FDA’s Kratom Focus Pivots To ‘Concentrated Synthetic Byproduct That Is An Opioid’

 

Explaining he was a heroin addict for 14 years more than 40 years ago “because it was so available,” Secretary Kennedy says “our agencies have been asleep in the wheel” but “now we're going to wake up and we're going to start to stop this before it starts.”

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By 

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.